|
| |
| | | 57961 | | 15.05.2008 | | Janssen-Cilag AG | | | | | | | | | | | | | 01.05. | | | | 01.05. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Invega 3 mg | Retardtabletten | Delayed release tablets (Paliperidonum 3 mg) | N05AX13 | CI | | 02 | Invega 6 mg | Retardtabletten | Delayed release tablets (Paliperidonum 6 mg) | N05AX13 | CI | | 03 | Invega 9 mg | Retardtabletten | Delayed release tablets (Paliperidonum 9 mg) | N05AX13 | CI | | 05 | Invega 1.5 mg, Retardtabletten | Retardtabletten | Delayed release tablets () | N05AX13 | CI |
|
|
|
